I can get to the abstract, Stormie, but not the full article. Our library, being one associated with a traditional allopathic medical school, doesn't have licensing/permission to that publication, which is the Journal of Cannabis Therapeutics. I intend to ask our librarian why not the first chance I get.

Here's a link to the abstract:
http://www.haworthpress.com/store/Ar...4F5MH0&ID=1474

Basically Dr. Fride's article summary explains that endocannabinoids (for others reading, that's our body's own natural in-born cannabinoid system, not the cannabinoids we take in through ingested cannabis) are critical for milk ingestion and appetite in newborns and so are linked to how newborns thrive. Dr. Fride proposes that in CF patients, the lipid-regulator gene that regulates the endocannabinoid system, affecting fatty acid synthesis, is out of whack and so those patients have lower levels of endocannabinoids. Thus she proposes that THC treatment may help those CF patients with appetite stimulation in addition to having anti-emetic, broncho-dilating, anti-inflammatory, anti-diarrheal, and hypoalgesic effects.

For our very weed-eager non-scientists here, that doesn't mean cannabis smoking is recommended by any stretch of the imagination for patients with cystic fibrosis. It simply means that the isolated THC compound itself may be very good for relieving the symptoms of CF.